4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-24-016544
Chief Executive Officer sold 1,125 shares at $55.27 ($62,179)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Santos da Silva Jorge Chief Executive Officer | 2024-02-21 | Sale 10b5-1 | −1,125 | $55.27 | $62,179 | 3,106,429 | D |
| Open-market sales · 1,125 sh · avg $55.27 · $62,179 | |||||||
Loading xslF345X05/ownership.xml…